What is on a 5-panel drug test?

The standard 5-panel drug test covers THC, cocaine, opiates, amphetamines/methamphetamine, and PCP. It mirrors the legacy federal "SAMHSA-5" composition and is the most common workplace screen in private-sector U.S. employment. For DOT-regulated employees, see the DOT 5-panel, which has been expanded since July 7, 2025 to include fentanyl and norfentanyl.

What's in a 5-panel

Cutoff levels

A "cutoff" is the analyte concentration at or above which a sample is reported as . The screening cutoff (immunoassay) is set higher than the confirmation cutoff (mass spectrometry) because screening is less specific. The federal Mandatory Guidelines define the cutoffs below; most private-sector 5-panels follow them.

Standard 5-Panel Drug Test — screening and confirmation cutoffs
Analyte Screen Confirm
THC-COOH (cannabinoid metabolite) 50 ng/mL 15 ng/mL
Benzoylecgonine (cocaine metabolite) 150 ng/mL 100 ng/mL
Opiates (morphine, codeine) 2000 ng/mL 2000 ng/mL
Amphetamine / methamphetamine 500 ng/mL 250 ng/mL
Phencyclidine (PCP) 25 ng/mL 25 ng/mL

5-panel vs DOT 5-panel

The two are not the same. Both contain THC, cocaine, opiates, amphetamines, and PCP, but the DOT 5-panel is federally regulated under 49 CFR Part 40, follows SAMHSA-certified laboratory procedures, and as of July 7, 2025 includes fentanyl and norfentanyl. A private-sector "5-panel" follows the same legacy composition but is not subject to federal procedural mandates and may use different cutoffs or analytes depending on the employer's program.

Who uses the 5-panel

  • Private-sector employers for pre-employment, random, reasonable-suspicion, and post-accident testing.
  • Background-check vendors as the default consumer-facing configuration.
  • Court-ordered or probation testing in jurisdictions that follow the legacy composition (varies).

Result interpretation

A 5-panel screen is interpreted in two steps: an immunoassay screening result and, if non-negative, a confirmation test by GC-MS or LC-MS/MS. A Medical Review Officer (MRO) reviews any non-negative confirmation result with the donor to identify any legitimate medical explanation (e.g., a prescription) before reporting a verified result to the employer.

Cannabis in restricted jurisdictions

Several U.S. states and municipalities now restrict employers from making employment decisions based on a positive cannabis test (subject to safety-sensitive and federal-contractor exceptions). In those jurisdictions, employers sometimes use a 4-panel that omits THC. See our cannabis & state law reference for the broader regulatory landscape.

Frequently asked questions

Sources & references

drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.

  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine) — SAMHSA
  2. 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs — U.S. Department of Transportation